rs78950939
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PP3_ModeratePP5_ModerateBS2_Supporting
The ENST00000225275.4(MPO):āc.518A>Gā(p.Tyr173Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000843 in 1,614,076 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y173H) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000225275.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPO | NM_000250.2 | c.518A>G | p.Tyr173Cys | missense_variant | 4/12 | ENST00000225275.4 | NP_000241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPO | ENST00000225275.4 | c.518A>G | p.Tyr173Cys | missense_variant | 4/12 | 1 | NM_000250.2 | ENSP00000225275 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000499 AC: 76AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000458 AC: 115AN: 250860Hom.: 1 AF XY: 0.000472 AC XY: 64AN XY: 135730
GnomAD4 exome AF: 0.000879 AC: 1285AN: 1461776Hom.: 2 Cov.: 32 AF XY: 0.000854 AC XY: 621AN XY: 727188
GnomAD4 genome AF: 0.000499 AC: 76AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000389 AC XY: 29AN XY: 74470
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2022 | Reported as a single heterozygous variant in an individual with complete MPO deficiency who was presumed to have a second undetected variant, and was also identified in the heterozygous state in several of his relatives with partial MPO deficiency (DeLeo et al., 1998); Reported as a heterozygous germline variant in several individuals with myeloid neoplasms (Kongkiatkamon et al., 2022); Published functional studies demonstrate a damaging effect: lack of mature MPO, retention in the endoplasmic reticulum, and significantly reduced MPO activity (DeLeo et al., 1998); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 36011324, 16183032, 20981092, 27013444, 9637725, 35761024) - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Myeloperoxidase deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 1998 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at